Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04JPG
|
||||
Former ID |
DIB007977
|
||||
Drug Name |
PF-04447943
|
||||
Synonyms |
PDE 9 inhibitor (Alzheimer's disease); PDE 9 inhibitor (Alzheimer's disease), Pfizer; Phosphodiesterase 9 inhibitor (Alzheimer's disease), Pfizer
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Investigative | [543409] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H25N7O2
|
||||
Canonical SMILES |
C1(CCOCC1)n1c2nc([nH]c(=O)c2cn1)[C@H](N1CC(C1)Oc1ccccc1<br />)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Phosphodiesterase (PDE) 9 | Target Info | Inhibitor | [543409] | |
KEGG Pathway | Purine metabolism | ||||
Pathway Interaction Database | Regulation of Androgen receptor activity | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.